Quarterly report pursuant to Section 13 or 15(d)

Issuances of Common Shares and Warrants (Details 2)

v3.24.2
Issuances of Common Shares and Warrants (Details 2) - USD ($)
 9 Months Ended 12 Months Ended
May 31, 2024
Aug. 31, 2023
Issuances of Common Shares and Warrants    
Beginning Balance, Outstanding 446,936 424,836
Expired/Cancelled (46,000) (47,500)
Exercised (2,500)  
Granted 436,500 69,600
Ending Balance, Outstanding 834,936 446,936
Ending Balance, Exercisable 684,936  
Weighted average exercise price, Beginning Balance, Outstanding $ 3.32 $ 6.45
Weighted Average Exercise price, Expired/Cancelled 2.98 2.98
Weighted Average Exercise Price, Exercised 1.15  
Weighted Average Exercise Price, Granted 1.24 1.75
Weighted Average Exercise Price, Beginning Balance, Outstanding 1.73 $ 3.32
Weighted Average Exercise Price, Exercisable $ 2.11  
Weighted Average Remaining Contractual Term, Outstanding (Years)   3 years 8 months 8 days
Weighted Average Remaining Contractual Term, Cancelled/expired 2 years 11 months 23 days 4 years 4 months 20 days
Weighted Average Remaining Contractual Term, Granted 4 years 7 months 28 days 2 years 11 months 23 days
Weighted Average Remaining Contractual Term, Outstanding 1 year 9 months 14 days 3 years 3 months
Weighted Average Remaining Contractual Term, Exercised 21 days  
Weighted Average Remaining Contractual Term, Exercisable (Years) 2 years 2 months 4 days  
Aggregate Intrinsic Value, Outstanding $ 977,561  
Aggregate Intrinsic Value, Exercisable $ 833,561